TNYA
Tenaya Therapeutics Inc
NASDAQ: TNYA · HEALTHCARE · BIOTECHNOLOGY
$0.69
+4.66% today
Updated 2026-04-30
Market cap
$145.87M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-0.59
Dividend yield
—
52W range
$0 – $2
Volume
4.3M
Tenaya Therapeutics Inc (TNYA) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Total assets | $38.00M | $148.16M | $316.65M | $278.94M | $170.51M | $119.94M |
| Cash & equivalents | $23.87M | $128.53M | $38.13M | $95.27M | $45.68M | $4.32M |
| Current assets | $27.74M | $129.96M | $255.36M | $193.75M | $111.58M | $67.38M |
| Total liabilities | $81.74M | $8.72M | $38.12M | $35.57M | $31.09M | $27.09M |
| Current liabilities | $4.12M | $5.04M | $21.77M | $24.25M | $22.73M | $15.97M |
| Long-term debt | — | — | — | — | — | — |
| Shareholder equity | $-43.74M | $139.44M | $278.53M | $243.38M | $139.42M | $92.85M |
| Retained earnings | $-44.42M | $-82.81M | $-155.53M | $-279.20M | $-403.28M | $-514.41M |
| Accounts receivable | — | — | — | $2.25M | — | — |
| Inventory | — | — | — | $-19.95M | — | — |
| Goodwill | — | — | — | — | — | — |